Seelos’ Investigational Therapy for FA Gets US Patent Protection  Friedreich’s Ataxia News

Seelos Therapeutics received a Notice of Allowance from the U.S. Patent and Trademark Office for SLS-005 (trehalose) to treat Friedreich’s ataxia.